{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38735192", "DateCompleted": {"Year": "2024", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "12"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.copbio.2024.103142", "S0958-1669(24)00078-8"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "11"}], "Journal": {"ISSN": "1879-0429", "JournalIssue": {"Volume": "87", "PubDate": {"Year": "2024", "Month": "Jun"}}, "Title": "Current opinion in biotechnology", "ISOAbbreviation": "Curr Opin Biotechnol"}, "ArticleTitle": "Plant synthetic biology for human health: advances in producing medicines in heterologous expression systems.", "Pagination": {"StartPage": "103142", "MedlinePgn": "103142"}, "Abstract": {"AbstractText": ["Plant synthetic biology has the capability to provide solutions to global challenges in the production and supply of medicines. Recent advances in 'omics' technologies have accelerated gene discoveries in medicinal plant research so that even multistep biosynthetic pathways for bioactive plant natural products with high structural complexity can be reconstituted in heterologous plant expression systems more rapidly. This review provides an overview of concept and strategies used to produce high-value plant natural products in heterologous plant systems and highlights recent successes in engineering the biosynthesis of conventional and new medicines in alternative plant hosts."], "CopyrightInformation": "Copyright \u00a9 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pelotonia Research Center, Department of Horticulture and Crop Science, the Ohio State University, 2255 Kenny Rd, Columbus, OH 43210, USA. Electronic address: sadre.2@osu.edu."}], "LastName": "Sadre", "ForeName": "Radin", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Curr Opin Biotechnol", "NlmUniqueID": "9100492", "ISSNLinking": "0958-1669"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": ["methods"], "DescriptorName": "Synthetic Biology"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biological Products"}, {"QualifierName": ["metabolism", "genetics", "chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Plants, Genetically Modified"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Plants"}, {"QualifierName": ["methods"], "DescriptorName": "Metabolic Engineering"}], "CoiStatement": "Declaration of Competing Interest The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2024", "Month": "3", "Day": "1"}, {"Year": "2024", "Month": "4", "Day": "23"}, {"Year": "2024", "Month": "6", "Day": "9", "Hour": "21", "Minute": "3"}, {"Year": "2024", "Month": "5", "Day": "13", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "5", "Day": "12", "Hour": "18", "Minute": "6"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38735192", "10.1016/j.copbio.2024.103142", "S0958-1669(24)00078-8"]}}]}